Catalyst
Slingshot members are tracking this event:
Phase 2 Open-Label Data Evaluating SAGE-217 in Major Depressive Disorder Due H1 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| SAGE |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 07, 2017
Occurred Source:
http://investor.sagerx.com/news-releases/news-release-details/sage-therapeutics-reports-positive-top-line-results-phase-2
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Sage-217, Major Depressive Disorder
